Clinical Trials on Togaviridae Infections

Total 56882 results

Ology Bioservices

Completed

Ross River Virus (RRV) Vaccine Study

Prophylaxis of Ross River Virus Infection

Australia
Ology Bioservices

Completed

Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801

Prophylaxis of Ross River Virus Infection

Australia
Centre Hospitalier Universitaire de Pointe-a-Pitre

Unknown

Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (CHIKIVIG-01)

Chikungunya Virus Infection

France
Valneva Austria GmbH

Completed

Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults

Chikungunya Virus Infection

United States
Valneva Austria GmbH

Completed

Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults

Chikungunya Virus Infection

United States
Centre Hospitalier Universitaire de la Réunion

Completed

Consequences of a Maternal-fetal Chikungunya Virus Infection (CHIK13+)

Chikungunya Virus Infection

Réunion
Themis Bioscience GmbH

Completed

Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)

Chikungunya Virus Infection

Austria, Germany
Themis Bioscience GmbH

Completed

Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)

Chikungunya Virus Infection

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Chikungunya Virus Infection

Dominican Republic, Puerto Rico, Guadeloupe, Haiti, Martinique
Bavarian Nordic
Emergent BioSolutions

Completed

Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

Chikungunya Virus Infection

United States
Institute of Tropical Medicine, Belgium

Withdrawn

RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection (CHIK_urine)

Chikungunya Fever

Belgium, Aruba
Valneva Austria GmbH

Active, not recruiting

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)

Chikungunya Virus Infection

United States
Themis Bioscience GmbH
Walter Reed Army Institute of Research (WRAIR)

Completed

Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)

Chikungunya Virus Infection

Puerto Rico
Unity Health Toronto

Completed

Rubella Susceptibility in Multiparous Women

Rubella | Vaccine

Canada
ModernaTX, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults

Prevention of Chikungunya Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Chikungunya Virus Vaccine Trial in Healthy Adults

Chikungunya Fever | Chikungunya Virus Infection | Viral Vaccines

United States
Hopital Foch

Completed

Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies (ImmRubVac)

Pregnancy

France
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Phase 1 Study of SAR440894 vs Placebo

Chikungunya Virus Infection

United States
Valneva Austria GmbH

Recruiting

A Phase 2 Clinical Study of VLA1553 in Healthy Children Aged 1 to 11 Years

Chikungunya Virus Infection

Dominican Republic, Honduras
Kaohsiung Medical University Chung-Ho Memorial...

Completed

The Pilot Study of Chikungunya Virus Infections in Southern Taiwan

Chikungunya Fever

Taiwan
Bavarian Nordic

Recruiting

Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination

Chikungunya Virus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Trial of Measles Vectored Chikungungya Vaccine

Chikungunya Virus Infection

United States
Centre Hospitalier Universitaire de Pointe-a-Pitre

Terminated

Yoga for Chronic Chikungunya (YOCHIK)

Chikungunya Virus Infection

Guadeloupe
PT Bio Farma

Completed

Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Measles | Congenital Rubella Infection

Indonesia
Gadjah Mada University
Monash University; The Tahija Foundation

Terminated

Applying Wolbachia to Eliminate Dengue (AWED)

Dengue | Chikungunya Fever | Zika Virus Infection

Indonesia
The Immunobiological Technology Institute (Bio-Manguinhos)...
Oswaldo Cruz Institute

Completed

Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella (BIOMR)

Measles | Rubella

Brazil
Universidad de Antioquia
United States Agency for International Development (USAID); Bill and Melinda... and other collaborators

Completed

Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia (WMP-COL)

Dengue | Zika Virus Infection | Chikungunya Virus Infection

Colombia
The Immunobiological Technology Institute (Bio-Manguinhos)...
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella (MR)

Measles | Rubella

Brazil
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Measles/Rubella

Japan
Micron Biomedical, Inc
Medical Research Council; Centers for Disease Control and Prevention

Completed

Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

Healthy | Measles | Rubella | Vaccination

Gambia
Takeda

Completed

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Measles/Rubella
GlaxoSmithKline

Completed

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Varicella | Chickenpox Vaccines

Russian Federation, Romania, Czechia, Slovakia, Italy, Sweden, Poland, Greece, Norway, Lithuania
Shanghai Institute Of Biological Products

Completed

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Vaccine | Immunotoxicity

China
Merck Sharp & Dohme LLC

Completed

ProQuad® Intramuscular vs Subcutaneous

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Measles | Rubella | Mumps | Varicella
PT Bio Farma

Completed

Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and Children

Safety Issues | Immunogenicity

Indonesia
University Hospital Center of Martinique
Institut National de la Santé Et de la Recherche Médicale, France; Clinique...

Recruiting

Cohort of Patients Infected by an Arbovirus (CARBO)

Fever | Dengue | Chikungunya | Zika Virus

France, French Guiana, Guadeloupe, Martinique, Réunion
National Institutes of Health Clinical Center (CC)

Completed

Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)

Dengue Virus | Zika Virus | Chikungunya Virus Infections

United States
Merck Sharp & Dohme LLC

Completed

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Measles | Rubella | Mumps | Varicella
Bavarian Nordic
Walter Reed Army Institute of Research (WRAIR); Emergent BioSolutions

Completed

Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) (WRAIR)

Chikungunya

United States
Themis Bioscience GmbH
Walter Reed Army Institute of Research (WRAIR)

Completed

Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area

Chikungunya

Puerto Rico
University of Oxford

Completed

Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)

Chikungunya Fever

United Kingdom
Assistance Publique - Hôpitaux de Paris
Service de Bactériologie-Virologie-Hygiène, CHU Limoge; GO-CIC network (Réseau... and other collaborators

Completed

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR (BREMEAVAC)

Measles | Rubella | Mumps

France
GlaxoSmithKline

Completed

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Measles | Rubella | Mumps
Rigshospitalet, Denmark

Completed

MMR at 6 Months Trial

Meales-mumps-rubella Vaccine

Denmark
Merck Sharp & Dohme LLC

Completed

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Terminated

A Study of ProQuad™ in Healthy Children in Korea (V221-023)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

ProQuad Dose Selection Study (V221-011)(COMPLETED)

Measles | Rubella | Mumps | Varicella

Clinical Trials on Togaviridae Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations